| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3900427 | Urology | 2013 | 7 Pages |
Abstract
Collectively, our results have demonstrated for the first time, to our knowledge, that Spry2 might offer an attractive new target for prognostic and therapeutic intervention in RCC.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Pu Li, Liangjun Tao, Jian Yang, Hongzhou Cai, Xiaobing Ju, Jie Li, Pengfei Shao, Qiang Cao, Chao Qin, Xiaoxin Meng, Changjun Yin,